Eye injection tested to stop diabetic blindness before it starts

This study tested whether a medication called aflibercept, injected into the eye, could improve poor blood flow in the retinas of people with diabetic retinopathy. Researchers enrolled 38 adults with moderate diabetic eye damage to see if the treatment could restore circulation and potentially prevent the disease from worsening to more severe, vision-threatening stages. The goal was to see if improving blood flow could be a new way to control the progression of this common diabetes complication.